CTRI/2023/12/060401尚未招募4 期
To study the efficacy of Metformin as an anti-hyperglycemic agent in patients requiring Insulin therapy during the induction phase of Acute Lymphoblastic Leukemia treatment - NI
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Treatment-naïve, newly diagnosed adults (= 18 years of age) with ALL requiring Insulin therapy for hyperglycemia during first 14 days of Induction chemotherapy, coming to the Department of Hematology after the Ethical approval for the study is granted, and providing informed consent for inclusion in the study, will be included in the study.
排除标准
- •Known case or newly diagnosed Diabetic individuals or Already on Metformin therapy or with Contra-Indications to Metformin therapy
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88
尚未招募
2 期
Metformin in Pemphigus VulgarisCondition 1: Pemphigus Vulgaris. Condition 2: Pemphigus foliaceus.Diseases of the skin and subcutaneous tissueIRCT20170822035834N2Sari University of Medical Sciences40
尚未招募
2 期
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160
招募中
3 期
The effect of the metformin in preventing of the preeclampsiaon severe preeclampsia.Mild to moderate pre-eclampsia, unspecified trimesterO14.00IRCT20210316050725N1Iran University of Medical Sciences52
已完成
3 期
Metformin as an adjunct therapy in mild-to-moderate ulcerative colitisUlcerative colitislcerative colitis.IRCT20181006041252N20Sabzevar University of Medical Sciences84